Regulatory Intelligence & Strategy
Regulatory Strategy & Consulting
Regulatory requirement mapping, compliance framework design, multi-jurisdiction harmonisation and regulatory strategy for pharmaceutical, biotechnology and medical device organisations operating across EU, UK, US, India and international markets.
Executive Overview
The regulatory landscape for pharmaceutical, biotechnology and medical device organisations spans multiple national and international frameworks, each with distinct requirements, interpretation traditions and enforcement priorities. Organisations that operate across these frameworks without a deliberate regulatory strategy consistently underperform — either over-investing in compliance through duplicated, jurisdiction-specific programmes or accumulating gaps because no single team owns the full picture.
Effective regulatory strategy begins with comprehensive mapping of what applies to your organisation, across all markets, all product types and all operations. It then requires a structured approach to building compliance frameworks that satisfy multiple requirements simultaneously, monitoring regulatory change and assessing its impact before it becomes an inspection observation.
Sthira Assure provides regulatory strategy consulting that is grounded in direct knowledge of EU, UK, US, India and international regulatory frameworks — not just the text of regulations but the current interpretation and enforcement practices of the regulators themselves. We work with Quality Directors, Regulatory Affairs Leaders and Compliance Managers to design compliance programmes that are robust, efficient and inspection-ready.
Regulatory Frameworks
- EU GMP Parts I & II
- FDA 21 CFR 210/211
- MHRA (Post-Brexit)
- ICH Q-Series
- CDSCO / Schedule M
- WHO GMP Guidelines
- PIC/S GMP
Discuss Your Regulatory Strategy
Speak with our team about your regulatory environment and compliance framework requirements.
Request a ConsultationCommon Compliance Risks
Regulatory Fragmentation Across Markets
Organisations operating across multiple regulatory jurisdictions face the challenge of maintaining compliance simultaneously with EU GMP, FDA 21 CFR, MHRA post-Brexit requirements, CDSCO and other national frameworks. Without a systematic mapping of requirements across these frameworks, organisations either over-invest in compliance activities or develop jurisdiction-specific silos that create inconsistencies and gaps. A harmonised regulatory strategy reduces duplication while ensuring each market's requirements are met.
Regulatory Change Without Impact Assessment
Pharmaceutical and medical device regulatory frameworks change continuously. New ICH guidelines, revised GMP annexes, updated FDA guidance documents and post-Brexit MHRA divergence all create compliance obligations that must be assessed and actioned. Organisations without systematic regulatory monitoring processes regularly discover compliance gaps only when inspectors raise observations — by which point the cost of remediation substantially exceeds the cost of prevention.
Inadequate Regulatory Due Diligence in M&A
Acquisitions and in-licensing transactions in regulated industries carry regulatory compliance risk that is distinct from commercial, financial and legal risk. Products with compliance gaps, manufacturing sites with regulatory history or quality systems that do not meet current expectations represent contingent liabilities that standard financial due diligence does not identify. Regulatory due diligence before transaction completion avoids post-acquisition surprises.
Market Entry Without Regulatory Readiness
Organisations entering new regulatory markets — whether expanding from the EU into the US, from India into European markets or from established markets into emerging regulatory environments — frequently underestimate the gap between their existing compliance posture and the requirements of the target market. A structured regulatory strategy, including gap assessment, remediation planning and regulatory authority engagement strategy, is essential for successful market entry.
Scope of Services
Typical Deliverables
Frequently Asked Questions
What does regulatory strategy consulting involve?
Regulatory strategy consulting covers the design and implementation of the compliance framework through which an organisation meets its regulatory obligations. This includes mapping applicable requirements across all relevant frameworks, designing control structures that satisfy multiple regulators simultaneously, assessing gaps between current practices and required standards, and developing prioritised remediation programmes. It is distinct from regulatory affairs support for product submissions, which focuses on dossier preparation and approval pathways.
How do you approach multi-jurisdiction regulatory harmonisation?
We begin with a comprehensive mapping of requirements across all applicable regulatory frameworks — identifying where requirements are equivalent, where they differ and where they conflict. From this foundation, we design a compliance framework that addresses the most stringent requirement in each area, eliminating the need for parallel, jurisdiction-specific quality systems wherever possible. Where genuine conflicts exist, we develop documented justification frameworks.
Can you support regulatory strategy for India market access?
Yes. We provide specific support for organisations navigating CDSCO requirements, Schedule M compliance and WHO-GMP certification in the context of India market access and export qualification. This includes gap assessment against current CDSCO expectations, regulatory strategy for WHO prequalification programmes and support for organisations seeking to bring Indian manufacturing into alignment with EU or US export requirements.
What is involved in regulatory due diligence for acquisitions?
Regulatory due diligence for pharmaceutical M&A involves review of target organisation regulatory history — inspection outcomes, warning letters, import alerts, notified body correspondence — assessment of current compliance status of manufacturing sites and product quality systems, evaluation of regulatory filing completeness and ongoing commitments, and identification of material regulatory risks that should affect transaction terms, warranties or post-acquisition remediation planning.
Design Your Regulatory Strategy
Contact our team to discuss your regulatory markets, compliance framework requirements and the strategy your organisation needs to operate with confidence.